Hedge Funds Aren’t Crazy About Charles River Laboratories (CRL) Anymore

Page 1 of 2

In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite money managers can beat the broader indices by a healthy margin (see just how much).

Charles River Laboratories (NYSE:CRL)

Just as useful, bullish insider trading activity is another way to analyze the financial markets. There are a variety of reasons for an upper level exec to get rid of shares of his or her company, but just one, very simple reason why they would buy. Various empirical studies have demonstrated the useful potential of this method if “monkeys” know what to do (learn more here).

Now that that’s out of the way, it’s important to discuss the newest info surrounding Charles River Laboratories (NYSE:CRL).

How are hedge funds trading Charles River Laboratories (NYSE:CRL)?

At Q2′s end, a total of 19 of the hedge funds we track held long positions in this stock, a change of -10% from the previous quarter. With the smart money’s capital changing hands, there exists an “upper tier” of notable hedge fund managers who were boosting their stakes considerably.

Out of the hedge funds we follow, Ariel Investments, managed by John W. Rogers, holds the biggest position in Charles River Laboratories (NYSE:CRL). Ariel Investments has a $112.2 million position in the stock, comprising 1.8% of its 13F portfolio. The second largest stake is held by Renaissance Technologies, managed by Jim Simons, which held a $48.6 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Other peers with similar optimism include David Dreman’s Dreman Value Management, Phill Gross and Robert Atchinson’s Adage Capital Management and Cliff Asness’s AQR Capital Management.

Because Charles River Laboratories (NYSE:CRL) has experienced a fall in interest from the smart money’s best and brightest, it’s easy to see that there exists a select few money managers that decided to sell off their full holdings at the end of the second quarter. It’s worth mentioning that Daniel Arbess’s Xerion cut the largest position of the 450+ funds we track, comprising about $2.5 million in stock. Dmitry Balyasny’s fund, Balyasny Asset Management, also said goodbye to its stock, about $2.2 million worth. These moves are important to note, as total hedge fund interest dropped by 2 funds at the end of the second quarter.

How have insiders been trading Charles River Laboratories (NYSE:CRL)?

Bullish insider trading is at its handiest when the company in focus has seen transactions within the past 180 days. Over the latest half-year time frame, Charles River Laboratories (NYSE:CRL) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Charles River Laboratories (NYSE:CRL). These stocks are Viropharma Inc (NASDAQ:VPHM), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Theravance Inc (NASDAQ:THRX), and Infinity Pharmaceuticals Inc. (NASDAQ:INFI). This group of stocks belong to the biotechnology industry and their market caps are closest to CRL’s market cap.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!